- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.07. | AstraZeneca, facing lung cancer challenge from J&J, touts life extension benefit for Tagrisso combo | ||
| 21.07. | Lundbeck, Otsuka's PTSD bid for Rexulti dealt a setback at FDA advisory committee | ||
| 21.07. | Biogen ups its ante in North Carolina, pledging $2B manufacturing investment | ||
| 21.07. | FDA names next CDER director in biotech vet George Tidmarsh | ||
| 21.07. | Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market | ||
| 18.07. | FDA mulls Elevidys market withdrawal following 3rd death after a Sarepta gene therapy | ||
| 18.07. | FDA rejects Roche's Columvi in earlier diffuse large B-cell lymphoma, citing lackluster US data | ||
| 18.07. | Bristol Myers braves failed Reblozyl ph. 3, plans FDA talks for potential anemia expansion | ||
| 18.07. | 3rd patient dies after receiving a Sarepta gene therapy | ||
| 18.07. | Moderna, facing uncertain business environment, scraps plan to establish mRNA plant in Japan | ||
| 18.07. | What's on neurologists' minds? Not drug names, survey shows | ||
| 18.07. | Bain Capital, Botanic move ahead with MA manufacturing facility designed to serve multiple biotechs | ||
| 18.07. | 'Hard to know what's going to happen': Big Pharmas put brave face on looming tariff threat | ||
| 17.07. | FDA advisors spurn GSK's Blenrep comeback dreams on safety, trial concerns | ||
| 17.07. | 'Abuse of power': Senators call out 'shady tactics' after investigating Pfizer, Lilly DTC platforms | ||
| 17.07. | As US cuts research funding, UK plans to invest billions in new biosecurity center | ||
| 17.07. | Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program | ||
| 17.07. | Novartis' Pluvicto finally picks up speed, delivers another trial win in early prostate cancer | ||
| 17.07. | Leo Pharma's slow response to app lapse scolded by UK marketing watchdog | ||
| 17.07. | After recall, Pfizer warns of 'near-term stock out' of penicillin product used to treat syphilis in pregnant women | ||
| 16.07. | For Lundbeck and Otsuka's PTSD filing, FDA questions Rexulti efficacy after failed phase 3 | ||
| 16.07. | FDA hands down citations to 3 drugmakers after inspections found contamination, testing concerns | ||
| 16.07. | J&J flexes $15B quarter for innovative drugs as biosimilars chip away at Stelara | ||
| 16.07. | AbbVie's Skyrizi, Novo's Wegovy duke it out in Q2 TV ad spending totals | ||
| 16.07. | Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .